To assess the efficacy of radioiodine therapy (RIT) and investigate the prognostic factors for
patients with pulmonary metastasis secondary to differentiated thyroid carcinoma (DTC) …

Context Data from a large cohort of patients with pulmonary metastases from differentiated
thyroid cancer (DTC) were retrospectively analyzed. Objective To assess the effect of …

Abstract Background Iodiene-131 (131 I) treatment is the primary therapeutic approach for
imaging 131 I-avid pulmonary metastases. The response to radioiodine (RAI) treatment is an …

Background Radioiodine therapy (RAI) after total or near-total thyroidectomy is a
recommended treatment for patients with pulmonary metastasis from differentiated thyroid …

Purpose To evaluate differences in clinical, radiological and laboratory findings between
pulmonary metastasis with and without radioiodine avidity in thyroidectomized differentiated …

Background Because one of the major sites for metastasis of thyroid cancers is the lung,
studying the pattern of pulmonary metastasis may provide useful information for the effective …

Background: Hyperfunctioning distant metastasis (HFDM) from differentiated thyroid cancer
(DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting …

Radioiodine therapy (RAI) has proven effective for the treatment of patients exhibiting
differentiated thyroid cancer (DTC) with pulmonary metastases. However, the early detection …

Distant metastasis (DM) is the dominant negative prognosis for thyroid carcinoma.
Radioactive iodine (RAI) therapy serves as an effective treatment for thyroid carcinoma …

Objective: Prognostic factors related to progression-free survival (PFS) have not received
much attention in the literature regarding iodine-131 (131 I) therapy for patients with …